Skip to Main Content

Paper Details

Zinc against COVID-19? Symptom surveillance and deficiency risk groups.
PLoS Negl Trop Dis
35
2021
COVID-19, Coronavirus 2, Coronavirus Disease 2019, SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2, Zinc, human, viral infection, zinc, zinc deficiency
Anti-Inflammatory Agents, COVID-19, COVID-19 Drug Treatment, Humans, Immune System, Oxidative Stress, Pandemics, Risk Factors, SARS-CoV-2, Zinc
Author NameAffiliation
Marcin P JoachimiakLawrence Berkeley National Laboratory
  • 1 - 1

Datasets

Release 1.2